Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Target has curated data in GtoImmuPdb
Target id: 2945
Nomenclature: Piezo1
Family: Piezo channels
Annotation status:
Awaiting annotation
» Email us
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 36 | 2521 | 16q24.3 | PIEZO1 | piezo type mechanosensitive ion channel component 1 (Er blood group) | |
Mouse | 35 | 2547 | 8 E1 | Piezo1 | piezo-type mechanosensitive ion channel component 1 | |
Rat | 35 | 2535 | 19q12 | Piezo1 | piezo-type mechanosensitive ion channel component 1 | |
Gene and Protein Information Comments | ||||||
Piezo proteins have between 24 and 36 predicted transmembrane (TM) domains, although a much lower number (14) of TM domains are resolved in the Piezo1 structure than initially predicted through topology software [3]. |
Previous and Unofficial Names ![]() |
FAM38A | family with sequence similarity 38, member A | KIAA0233 | Mib | PIEZ1 | piezo type mechanosensitive ion channel component 1 |
Database Links ![]() |
|
Alphafold | Q92508 (Hs), E2JF22 (Mm), Q0KL00 (Rn) |
Ensembl Gene | ENSG00000103335 (Hs), ENSMUSG00000014444 (Mm), ENSRNOG00000056786 (Rn) |
Entrez Gene | 9780 (Hs), 234839 (Mm), 361430 (Rn) |
Human Protein Atlas | ENSG00000103335 (Hs) |
KEGG Gene | hsa:9780 (Hs), mmu:234839 (Mm), rno:361430 (Rn) |
OMIM | 611184 (Hs) |
Orphanet | ORPHA303176 (Hs) |
Pharos | Q92508 (Hs) |
RefSeq Nucleotide | NM_001142864 (Hs), NM_001037298 (Mm), NM_001077200 (Rn) |
RefSeq Protein | NP_001136336 (Hs), NP_001032375 (Mm), NP_001070668 (Rn) |
UniProtKB | Q92508 (Hs), E2JF22 (Mm), Q0KL00 (Rn) |
Wikipedia | PIEZO1 (Hs) |
Selected 3D Structures ![]() |
|||||||||||
![]() |
|
Endogenous modulators (Human) |
Cholesterol, 7-ketocholesterol, phosphatidylserine, phosphatidylinositol 4,5-bisphosphate, ceramide, docosahexaenoic acid, eicosapentaenoic acid, margaric acid, protons, amyloid beta (1-40) peptide |
Physical activators (Human) |
Membrane stretch, cell indentation, fluid shear stress, cell traction force, substrate stiffening |
Download all structure-activity data for this target as a CSV file
Activators | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific activator tables |
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inhibitor Comments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The small molecule OB-1 disrupts self-association of the STOML3 Piezo channel modulator [16]. This mechanism reverses pathological mechanical hypersensitivity that is mediated by Piezo ion channels. |
Immunopharmacology Comments |
Work by Liu et al. (2018) shows that Piezo1 is involved in immune regulation [8]. Piezo1 signalling appears to cause a rearrangement of the actin scaffold, that connects this mechanosensor's function to optimal T cell receptor signalling and T cell activation. Knock out of Piezo1 channels in the innate immune cells of mice has shown that mechanosensation of force by Piezo1 in the lung is an essential component of innate immune system-mediated inflammatory reponses [12]. |
Cell Type Associations | ||||||
|
Tissue Distribution ![]() |
||||||||
|
Physiological Functions ![]() |
||||||||
|
1. Bae C, Sachs F, Gottlieb PA. (2011) The mechanosensitive ion channel Piezo1 is inhibited by the peptide GsMTx4. Biochemistry, 50 (29): 6295-300. [PMID:21696149]
2. Coste B, Mathur J, Schmidt M, Earley TJ, Ranade S, Petrus MJ, Dubin AE, Patapoutian A. (2010) Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science, 330 (6000): 55-60. [PMID:20813920]
3. Coste B, Murthy SE, Mathur J, Schmidt M, Mechioukhi Y, Delmas P, Patapoutian A. (2015) Piezo1 ion channel pore properties are dictated by C-terminal region. Nat Commun, 6: 7223. [PMID:26008989]
4. Evans EL, Cuthbertson K, Endesh N, Rode B, Blythe NM, Hyman AJ, Hall SJ, Gaunt HJ, Ludlow MJ, Foster R et al.. (2018) Yoda1 analogue (Dooku1) which antagonizes Yoda1-evoked activation of Piezo1 and aortic relaxation. Br J Pharmacol, 175 (10): 1744-1759. [PMID:29498036]
5. Ge J, Li W, Zhao Q, Li N, Chen M, Zhi P, Li R, Gao N, Xiao B, Yang M. (2015) Architecture of the mammalian mechanosensitive Piezo1 channel. Nature, 527 (7576): 64-9. [PMID:26390154]
6. Goon S, Shiu Chen Liu C, Ghosh Dastidar U, Paul B, Mukherjee S, Sarkar HS, Desai M, Jana R, Pal S, Sreedevi NV et al.. (2024) Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation. J Med Chem, 67 (10): 8225-8246. [PMID:38716967]
7. Liang P, Zhang Y, Wan YCS, Ma S, Dong P, Lowry AJ, Francis SJ, Khandelwal S, Delahunty M, Telen MJ et al.. (2024) Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosis. Blood, 143 (4): 357-369. [PMID:38033286]
8. Liu CSC, Raychaudhuri D, Paul B, Chakrabarty Y, Ghosh AR, Rahaman O, Talukdar A, Ganguly D. (2018) Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation. J Immunol, 200 (4): 1255-1260. [PMID:29330322]
9. Ludlow MJ, Povstyan OV, Linley DM, Martin-Almedina S, Revill C, Cuthbertson K, Smith KA, Fay E, Fotiou E, Bush A et al.. (2025) PIEZO1 mechanical insensitivity in generalized lymphatic dysplasia with the potential for pharmacological rescue. iScience, Epun ahead of print. DOI: 10.1016/j.isci.2025.113110
10. Pan X, Wan R, Wang Y, Liu S, He Y, Deng B, Luo S, Chen Y, Wen L, Hong T et al.. (2022) Inhibition of chemically and mechanically activated Piezo1 channels as a mechanism for ameliorating atherosclerosis with salvianolic acid B. Br J Pharmacol, 179 (14): 3778-3814. [PMID:35194776]
11. Parsonage G, Cuthbertson K, Endesh N, Murciano N, Hyman AJ, Revill CH, Povstyan OV, Chuntharpursat-Bon E, Debant M, Ludlow MJ et al.. (2023) Improved PIEZO1 agonism through 4-benzoic acid modification of Yoda1. Br J Pharmacol, 180 (16): 2039-2063. [PMID:36457143]
12. Solis AG, Bielecki P, Steach HR, Sharma L, Harman CCD, Yun S, de Zoete MR, Warnock JN, To SDF, York AG et al.. (2019) Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity. Nature, 573 (7772): 69-74. [PMID:31435009]
13. Syeda R, Xu J, Dubin AE, Coste B, Mathur J, Huynh T, Matzen J, Lao J, Tully DC, Engels IH et al.. (2015) Chemical activation of the mechanotransduction channel Piezo1. Elife, 4. [PMID:26001275]
14. Wang Y, Chi S, Guo H, Li G, Wang L, Zhao Q, Rao Y, Zu L, He W, Xiao B. (2018) A lever-like transduction pathway for long-distance chemical- and mechano-gating of the mechanosensitive Piezo1 channel. Nat Commun, 9 (1): 1300. [PMID:29610524]
15. Wang Y, Chu T, Pan X, Bian Y, Li J. (2023) Escin ameliorates inflammation via inhibiting mechanical stretch and chemically induced Piezo1 activation in vascular endothelial cells. Eur J Pharmacol, 956: 175951. [PMID:37541373]
16. Wetzel C, Pifferi S, Picci C, Gök C, Hoffmann D, Bali KK, Lampe A, Lapatsina L, Fleischer R, Smith ES et al.. (2017) Small-molecule inhibition of STOML3 oligomerization reverses pathological mechanical hypersensitivity. Nat Neurosci, 20 (2): 209-218. [PMID:27941788]
17. Xie Z, Rose L, Feng J, Zhao Y, Lu Y, Kane H, Hibberd TJ, Hu X, Wang Z, Zang K et al.. (2025) Enteric neuronal Piezo1 maintains mechanical and immunological homeostasis by sensing force. Cell, 188 (9): 2417-2432.e19. [PMID:40132579]
18. Yu D, Bae C. (2025) Propofol inhibits Piezo mechanosensitive channels. Biophys J, [Epub ahead of print]. [PMID:40485107]
Last modified on 21/07/2025.
The citation format for the published version of this page will be:
Piezo channels: Piezo1. Last modified on 21/07/2025. Accessed on 12/09/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2945.